S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q2 2023

BVF Partners

Period: Q2 2023 Β· Filed: 2023-08-14
View on SEC EDGAR β†—
AUM
$3.59B
Total portfolio value
Positions
67
Reported securities
Top Holding
MLTX
30.9% $1.11B
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.11B30.92%$51.00$18.95-62.8%
30.9%
RVMDREVOLUTION MEDICINES INC$167.3M4.66%$26.75$189.24+607.4%
4.7%
AXSMAXSOME THERAPEUTICS INC$153.1M4.27%$71.86$244.31+240.0%
4.3%
IDYAIDEAYA BIOSCIENCES INC$133.6M3.72%$23.50$37.65+60.2%
3.7%
IONSIONIS PHARMACEUTICALS INC$116.8M3.25%$41.03$81.80+99.4%
3.3%
GHRSGH RESEARCH PLC$110.0M3.07%$11.86$27.01+127.7%
3.1%
KYMRKYMERA THERAPEUTICS INC$109.0M3.04%$22.99$113.51+393.7%
3.0%
PTGXPROTAGONIST THERAPEUTICS INC$104.3M2.91%$27.62$131.62+376.5%
2.9%
PNTPOINT BIOPHARMA GLOBAL INC$95.7M2.67%β€”β€”
2.7%
LKFTGALAPAGOS NV$88.0M2.45%$40.66$30.39-25.3%
2.5%
RPTXREPARE THERAPEUTICS INC$87.7M2.45%β€”β€”
2.5%
GPCRSTRUCTURE THERAPEUTICS INC$72.8M2.03%$41.57$53.45+28.6%
2.0%
FDMT4D MOLECULAR THERAPEUTICS IN$72.4M2.02%$18.07$13.00-28.1%
2.0%
KURAKURA ONCOLOGY INC$71.2M1.98%$10.58$11.10+4.9%
2.0%
XENEXENON PHARMACEUTICALS INC$70.4M1.96%$38.50$60.96+58.3%
2.0%
OLMAOLEMA PHARMACEUTICALS INC$68.7M1.92%$9.03$12.64+40.0%
1.9%
XOMAXOMA CORP DEL$68.6M1.91%$18.89$43.00+127.6%
1.9%
CNTACENTESSA PHARMACEUTICALS PLC$58.3M1.63%$6.19$40.50+554.3%
1.6%
ZYMEZYMEWORKS INC$50.7M1.41%$8.64$26.31+204.5%
1.4%
REPLREPLIMUNE GROUP INC$49.8M1.39%$23.22$11.58-50.1%
1.4%
JANXJANUX THERAPEUTICS INC$48.8M1.36%$11.87$15.54+30.9%
1.4%
TYRATYRA BIOSCIENCES INC$46.7M1.30%$17.03$30.62+79.8%
1.3%
LXRXLEXICON PHARMACEUTICALS INC$45.8M1.28%$2.29$2.32+1.3%
1.3%
MRUSMERUS N V$42.2M1.18%β€”β€”
1.2%
RLAYRELAY THERAPEUTICS INC$39.2M1.09%$12.56$18.65+48.5%
1.1%
ALLKALLAKOS INC$37.7M1.05%β€”β€”
1.1%
ETNB89BIO INC$35.0M0.98%β€”β€”
1.0%
ACRSACLARIS THERAPEUTICS INC$34.9M0.97%$10.37$5.56-46.4%
1.0%
CGEMCULLINAN ONCOLOGY INC$34.4M0.96%$10.76$17.63+63.9%
1.0%
ITOSITEOS THERAPEUTICS INC$24.0M0.67%β€”β€”
0.7%

Quarter-on-Quarter Activity

Q2 2023 vs. Q1 2023

New Positions (6)

TickerIssuerNotional
VSTMVERASTEM INC$12.5M
TCRXTSCAN THERAPEUTICS INC$7.5M
DCTHDELCATH SYS INC$6.9M
KRONKRONOS BIO INC$4.8M
ASLNASLAN PHARMACEUTICALS LTD$3.8M
GLMDGALMED PHARMACEUTICALS LTD$0.3M

Exited Positions (8)

TickerIssuerNotional
SNDXSYNDAX PHARMACEUTICALS INC$45.3M
CRNXCRINETICS PHARMACEUTICALS IN$44.0M
IMVTIMMUNOVANT INC$39.7M
CTICCTI BIOPHARMA CORP$37.0M
VSTMXXXXVERASTEM INC$7.9M
ALPNALPINE IMMUNE SCIENCES INC$6.6M
VRDNVIRIDIAN THERAPEUTICS INC$4.3M
HLVXHILLEVAX INC$4.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
PIRSPIERIS PHARMACEUTICALS INC$-1.6M+305.7%
JANXJANUX THERAPEUTICS INC$29.6M+159.0%+30.9%
IDYAIDEAYA BIOSCIENCES INC$99.8M+131.5%+60.2%
ELDNELEDON PHARMACEUTICALS INC$0.4M+86.0%
ALLKALLAKOS INC$10.8M+42.8%
RVMDREVOLUTION MEDICINES INC$60.0M+26.2%+607.4%
LXRXLEXICON PHARMACEUTICALS INC$6.5M+23.8%+1.3%
IONSIONIS PHARMACEUTICALS INC$25.3M+11.1%+99.4%

Trimmed (2)

TickerIssuerNotionalShares Ξ”Since Filing
MRUSMERUS N V$-12.6M-46.2%
TYRATYRA BIOSCIENCES INC$-5.4M-15.4%+79.8%
← Back to Hedge Funds